Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/3/16 → 5/3/21 |
Funding
- Quintiles, Inc. (Prot #RPC01-3101 // Prot #RPC01-3101)
- Celgene International II Sàrl (Prot #RPC01-3101 // Prot #RPC01-3101)
Prot #RPC01-3101: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
- Hanauer, stephen B (PD/PI)
Project: Research project